Amanote Research
Register
Sign In
FDA to Review Risks of Antidepressants in Adults
BMJ
doi 10.1136/bmj.329.7470.816-b
Full Text
Open PDF
Abstract
Available in
full text
Date
October 9, 2004
Authors
J. Lenzer
Publisher
BMJ
Related search
Risks of Tricyclic Antidepressants
British Journal of Psychiatry
Medicine
Psychiatry
Mental Health
FDA Urges "Black Box" Warning on Pediatric Antidepressants
CMAJ
Medicine
Antidepressants and the Risks of Untreated Illnesses
Psychiatric Bulletin
Antidepressants for Minors: Benefits, Risks and Peter Gøtzsche
Bipolar Disorders
Psychiatry
Biological Psychiatry
Mental Health
FDA Bars Own Expert From Evaluating Risks of Painkillers
BMJ
Drug Suicide Risks Prompt Call for FDA Action
Nature
Multidisciplinary
Antidepressants and Suicide Risk: How Did Specific Information in FDA Safety Warnings Affect Treatment Patterns?
Psychiatric Services
Medicine
Psychiatry
Mental Health
Risks of Statin Therapy in Older Adults
JAMA Internal Medicine
Internal Medicine
Risks of Intracranial Haematoma in Head Injured Adults
BMJ